GSK-3β is involved in glucose metabolism and is dysregulated in metabolic diseases (Nusse and Clevers, 2017), and the Wnt/β-catenin pathway is activated in metabolic diseases such as diabetes (Chen et al., 2018). This evidence concerns the gene GSK3B and Other metabolic disease.